Skip to main content

Lupus News

FDA Alert
10/20/2025
Rebecca Mashaw
Obinutuzumab is the only anti-CD20 monoclonal antibody to demonstrate a complete renal response benefit in lupus nephritis in a randomized Phase III study.
Obinutuzumab is the only anti-CD20 monoclonal antibody to demonstrate a complete renal response benefit in lupus nephritis in a randomized Phase III study.
Obinutuzumab is the only...
10/20/2025
Rheumatology & Arthritis
News
07/29/2025
Jessica Garlewicz
These findings offer clarification amid previously conflicting data on HCQ’s renal benefits in LN and underscore the importance of long-term HCQ adherence.
These findings offer clarification amid previously conflicting data on HCQ’s renal benefits in LN and underscore the importance of long-term HCQ adherence.
These findings offer...
07/29/2025
Rheumatology & Arthritis
News
07/24/2025
Rebecca Mashaw
A new study highlights the added value of systemic disease control in conjunction with renal response for patients with lupus nephritis.
A new study highlights the added value of systemic disease control in conjunction with renal response for patients with lupus nephritis.
A new study highlights the added...
07/24/2025
Rheumatology & Arthritis
News
07/10/2025
Jessica Garlewicz
Ongoing efforts to address geographic and racial disparities remain central to further reducing mortality in SLE.
Ongoing efforts to address geographic and racial disparities remain central to further reducing mortality in SLE.
Ongoing efforts to address...
07/10/2025
Rheumatology & Arthritis
News
06/10/2025
Jessica Garlewicz
For practicing rheumatologists, this study reinforces the relevance of frailty as a clinical construct in systemic lupus erythematosus.
For practicing rheumatologists, this study reinforces the relevance of frailty as a clinical construct in systemic lupus erythematosus.
For practicing rheumatologists,...
06/10/2025
Rheumatology & Arthritis
News
06/10/2025
Jessica Garlewicz
Tese findings highlight the importance of screening for social isolation and emotional well-being as part of comprehensive care in older adults with systemic lupus erythematosus.
Tese findings highlight the importance of screening for social isolation and emotional well-being as part of comprehensive care in older adults with systemic lupus erythematosus.
Tese findings highlight the...
06/10/2025
Rheumatology & Arthritis
News
06/10/2025
Jessica Garlewicz
This study offers compelling evidence for the integration of frailty assessment into routine clinical care for systemic lupus erythematosus.
This study offers compelling evidence for the integration of frailty assessment into routine clinical care for systemic lupus erythematosus.
This study offers compelling...
06/10/2025
Rheumatology & Arthritis
News
05/23/2025
Rebecca Mashaw
Incorporating frailty assessment into routine clinical evaluation may help clinicians identify interventions to preserve quality of life among patients with systemic lupus erythematosus.
Incorporating frailty assessment into routine clinical evaluation may help clinicians identify interventions to preserve quality of life among patients with systemic lupus erythematosus.
Incorporating frailty assessment...
05/23/2025
Rheumatology & Arthritis
News
03/07/2025
Jessica Garlewicz
Findings of a recent study highlight the need for clinicians to consider both the purpose and feasibility of frailty assessment when selecting a measure.
Findings of a recent study highlight the need for clinicians to consider both the purpose and feasibility of frailty assessment when selecting a measure.
Findings of a recent study...
03/07/2025
Rheumatology & Arthritis
News
01/07/2025
Riya Gandhi, MA
A population-based cohort study reveals that patients with systemic lupus erythematosus (SLE) are at a significantly higher risk of multimorbidity, with an increased burden even before disease onset.
A population-based cohort study reveals that patients with systemic lupus erythematosus (SLE) are at a significantly higher risk of multimorbidity, with an increased burden even before disease onset.
A population-based cohort study...
01/07/2025
Rheumatology & Arthritis